Structure Therapeutics, Inc. is a clinical stage global biopharmaceutical company, which engages in developing novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its pipeline includes Aleniglipron GSBR-1290, ACCG-2671, GIPR, GCGR, ANPA-0073, and LTSE-2578. The company was founded by Raymond C. Stevens in 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
220
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Structure Therapeutics Inc - ADR market cap is $1.15B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Structure Therapeutics Inc - ADR 52 week high is $94.90 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Structure Therapeutics Inc - ADR 52 week low is $16.06 as of November 22, 2026.
Structure Therapeutics Inc - ADR stock price today is $16.13.
Structure Therapeutics Inc - ADR stock price yesterday was $17.12.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Structure Therapeutics Inc - ADR's P/E ratio is -4.09.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Structure Therapeutics Inc - ADR P/B ratio is 0.9421.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Structure Therapeutics Inc - ADR 50-day moving average is $25.49.
Structure Therapeutics Inc - ADR has 220 employees.